Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
28.00
Ask:
30.00
Spread: 2.00 (7.143%)
Market Cap: £52.44m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

Directorate Change

29 Nov 2018 07:00

RNS Number : 8321I
Ilika plc
29 November 2018
 

Ilika plc

("Ilika" and the "Company")

 

Directorate Change

Formation of Technology Advisory Board

 

Ilika plc (AIM: IKA), the advanced solid-state battery technology company, announces the appointment of Keith Jackson as Chairman from the 1st January 2019, when Mike Inglis will step down from the Board.

 

Keith Jackson has been a Non-Executive Director of Ilika since 2014 and is also currently Chief Technology Officer at Meggitt plc, where he is responsible for technology direction and strategy. Keith has had a wide-ranging and successful career in companies varying from start-ups to multinationals. He founded and as CEO grew automotive control systems company Pi Technology. Following the successful sale of the company to Ford, he joined Rolls Royce plc and became Chief Technology Officer in the electrical power and control systems group. Keith is a Fellow of the Society of Automotive Engineers and is a graduate from University College London.

 

Mike Inglis was appointed a Non-Executive Director of Ilika in July 2015 and Chairman in September 2015. He has chosen the completion of a three-year period as Chairman to step down for capacity reasons following increased committee activities on his other boards. Mike will remain involved with Ilika and become the founding member of Ilika's Technology Advisory Board, a team of industry experts to advise on the commercialisation of Ilika's technology with specialist sector knowledge.

 

Graeme Purdy, CEO, stated: "We are very grateful to Mike for the direction he has given the Ilika board over the past three years. He has assisted greatly in setting up the commercial framework we have established for bringing our Stereaxâ technology to market. I am delighted that Mike has agreed to be the founding member of Ilika's Technology Advisory Board, which will be used to contribute to Ilika's strategic direction in the coming years."

 

Mike Inglis, Chairman, added: "I have been impressed with the commercial and technical progress achieved by Ilika during my period as Chairman and I am pleased to hand over to Keith, who provides strategic continuity and brings a wealth of commercial experience, international technology and manufacturing experience to guide Ilika in its next phase."

 

Keith Jackson, Chairman elect, added: "I am delighted to accept the opportunity to guide Ilika's board as we take the Company into its next phase of commercial exploitation."

 

For more information contact:

 

Ilika plc

 

www.ilika.com

 

 

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan

Trystan Cullen, William Hall

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMMZMRRVGRZM
Date   Source Headline
23rd Apr 20122:44 pmRNSHolding(s) in Company
23rd Apr 20128:01 amRNSDirector/PDMR Shareholding
20th Apr 201212:49 pmRNSGeneral Meeting Results
4th Apr 201212:26 pmRNSPosting of circular
4th Apr 20127:00 amRNSPlacing and Subscription
13th Mar 20127:00 amRNSContract Renewals and Trading Update
2nd Feb 20127:00 amRNSJoint Development agreement with Energizer
10th Jan 20127:00 amRNSHalf Yearly Report
9th Jan 20127:00 amRNSNew contract with Toshiba
6th Dec 20117:00 amRNSAltrika grant award and new JDP
28th Nov 20117:00 amRNSSolid State Battery Development
16th Nov 20117:00 amRNSTrading Update
29th Sep 20118:21 amRNSFirst US electronics contract / Expansion in Asia
13th Sep 20115:06 pmRNSResult of AGM
2nd Aug 20117:00 amRNSPosting of annual report
14th Jul 20117:00 amRNSFull Year Results
4th May 20117:00 amRNSTrading Update
18th Apr 20117:00 amRNSCarbon Trust Grant / New Customer Contract
4th Mar 20118:00 amRNSRenewal of Contracts
24th Feb 20112:56 pmRNSNotification of Interest
23rd Feb 201112:16 pmRNSNotification of Interest
19th Jan 20113:00 pmRNSDISTRIBUTION OF INTERIM ACCOUNTS FOR 2010
24th Nov 20107:00 amRNSInterim Results
29th Oct 20107:00 amRNSIlika awarded Carbon Trust R&D Grant
21st Oct 20107:00 amRNSAgreement with Ministry of Defence agency
21st Oct 20107:00 amRNSAgreement with Ministry of Defence agency
20th Oct 20104:35 pmRNSAnnual Financial Report
20th Oct 20104:35 pmRNSAnnual Financial Report
8th Oct 201010:30 amRNSInternational Business Development Appointments
8th Sep 20107:00 amRNSRevenue Update and Contract Renewal
18th Aug 20104:13 pmRNSNotification of Interest
17th Aug 20107:00 amRNSTotal Voting Rights
5th Aug 20104:05 pmRNSHolding(s) in Company
28th Jul 20107:00 amRNSUK Government Grant for Skin Wound Treatment
15th Jul 20107:00 amRNSFuel Cell Materials Joint Development Project
15th Jul 20107:00 amRNSFinal Results
30th Jun 20107:00 amRNSDevelopment Project
16th Jun 20107:00 amRNSFuel cell catalyst scale-up agreement
10th Jun 201012:39 pmRNSInspection, Regulatory Authority for Skin Products
9th Jun 20109:25 amRNSIlika partners to develop business in China
2nd Jun 20104:25 pmRNSExercise of Options
14th May 20105:16 pmRNSGrant of Options
14th May 20105:16 pmRNSGrant of Options
14th May 20108:02 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.